NCT00907998View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

PHASE1CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

October 31, 2009

Conditions
Coronary Heart Disease
Interventions
DRUG

APL180

DRUG

APL180

DRUG

Placebo

Trial Locations (11)

78230

Icon Clinical Research, San Antonio

AL36207

Pinnacle Research Group, Anniston

Unknown

Novartis Investigative Site, Philadelphia

Novartis Investigator Site, Copenhagen

Novartis Investigator Site, Mainz

Novartis Investigator Site, Mannheim

Novartis Investigator Site, Neuss

Novartis Investigator Site, Rehovot

Novartis Investigator Site, Tel Aviv

Novartis Investigator Site, Zrifin

Novartis Investigator Site, Amsterdam

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY